<SEC-DOCUMENT>0001731122-25-000961.txt : 20250711
<SEC-HEADER>0001731122-25-000961.hdr.sgml : 20250711
<ACCEPTANCE-DATETIME>20250711162001
ACCESSION NUMBER:		0001731122-25-000961
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20250711
DATE AS OF CHANGE:		20250711

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FONAR CORP
		CENTRAL INDEX KEY:			0000355019
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				112464137
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-33323
		FILM NUMBER:		251119218

	BUSINESS ADDRESS:	
		STREET 1:		110 MARCUS DR
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6316942929

	MAIL ADDRESS:	
		STREET 1:		110 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Damadian Timothy Raymond
		CENTRAL INDEX KEY:			0001949366
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D

	MAIL ADDRESS:	
		STREET 1:		110 MARCUS DR.
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Damadian Timothy Raymond -->
          <cik>0001949366</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock, $0.0001 par value per share</securitiesClassTitle>
      <dateOfEvent>07/07/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0000355019</issuerCIK>
        <issuerCUSIP>344437108</issuerCUSIP>
        <issuerName>FONAR Corp</issuerName>
        <address>
          <com:street1>110 MARCUS DR</com:street1>
          <com:city>Melville</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>11747</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Dennis C. O'Rourke, Esq.</personName>
          <personPhoneNum>516-873-2000</personPhoneNum>
          <personAddress>
            <com:street1>Moritt Hock &amp; Hamroff LLP</com:street1>
            <com:street2>400 Garden City Plaza</com:street2>
            <com:city>Garden City</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>11530</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001949366</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Timothy Raymond Damadian</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>PF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>121553.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>121553.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>121553.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>1.9</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Luciano Benedetto Bonanni</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>PF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>54253.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>54253.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>54253.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0.9</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Ronald George Lehman II</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>4330.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>4330.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>4330.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0.1</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Richard Alan Feigenbaum</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>0.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Xavier Patrick Rodrigo</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>37196.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>37196.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>37196.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0.6</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Jevan Damadian</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>PF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>78853.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>78853.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>78853.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>1.3</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>James Joseph Flanagan</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>PF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>8851.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>8851.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>8851.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0.1</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Kurt William Reimann</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>PF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>2000.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>2000.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>2000.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0.1</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Janice Veroline</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>7697.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>7697.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>7697.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0.1</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>James Persoons</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
        <aggregateAmountOwned>0.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>0</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, $0.0001 par value per share</securityTitle>
        <issuerName>FONAR Corp</issuerName>
        <issuerPrincipalAddress>
          <com:street1>110 MARCUS DR</com:street1>
          <com:city>Melville</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>11747</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>This statement on Schedule 13D relates to shares of common stock, par value $0.0001 per share  ("Common Stock"), of FONAR Corporation, a Delaware corporation (the "Issuer"). The principal executive offices of the Issuer are located at 110 Marcus Drive, Melville, New York 11747.</commentText>
      </item1>
      <item2>
        <filingPersonName>This Schedule 13D is being jointly filed pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended (the "Exchange Act") on behalf of:
1. Timothy Raymond Damadian ("T. Damadian")
2. Luciano Benedetto Bonanni ("Bonanni")
3. Ronald George Lehman II ("Lehman")
4. Richard Alan Feigenbaum ("Feigenbaum")
5. Xavier Patrick Rodrigo ("Rodrigo")
6. Jevan Damadian ("J. Damadian")
7. James Joseph Flanagan ("Flanagan")
8. Kurt William Reimann ("Reimann")
9. Janice Veroline ("Veroline")
10. James Persoons ("Persoons")
The foregoing persons are hereinafter sometimes referred to collectively, as "Reporting Persons" and individually, as a "Reporting Person."</filingPersonName>
        <principalBusinessAddress>With respect to each of T. Damadian, Bonanni, Feigenbaum, Rodrigo, J. Damadian, Flanagan, Reimann, Veroline and Persoons, the address of such person's principal office and principal place of business is 110 Marcus Drive, Melville, New York 11747-4292.

With respect to Lehman, the address of his principal office and principal place of business is c/o Sandy Hill Inc., 64 Birch Hill Rd, Locust Valley, New York 11560.</principalBusinessAddress>
        <principalJob>T. Damadian, a natural person, is the Chairman of the Board of Directors and Chief Executive Officer of the Issuer.

Bonanni, a natural person, is the Vice President, Chief Operating Officer and Acting Principal Financial Officer of the Issuer.

Lehman, a natural person and a private equity investor, is Managing Director and Head of Investment Banking at Bruderman Advisory Group, LLC and is a partner of, and employed by, Sandy Hill Inc. Lehman is a director of the Issuer.

Feigenbaum, a natural person, is the Chief Financial Officer of Health Diagnostics Management, LLC, d/b/a Health Management Company of America ("HMCA"). HMCA is a 70% owned subsidiary of Health Management Corporation of America, which, in turn, is a wholly-owned subsidiary of the Issuer.

Rodrigo, a natural person, is the Vice President of Operations of HMCA.

J. Damadian, a natural person, is the Director of Business Development of the Issuer.

Flanagan, a natural person, is the Vice President of Project Management of HMCA.

Reimann, a natural person, is the Managing Director of HMCA.

Veroline, a natural person, is the Vice President of Human Resources of HMCA.

Persoons, a natural person, is the Vice President of New York Operations of HMCA.</principalJob>
        <hasBeenConvicted>During the last five years, none of the Reporting Persons have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>During the last five years, none of the Reporting Persons have been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violations with respect to such laws.</convictionDescription>
        <citizenship>Each Reporting Person is a citizen of the United States of America.</citizenship>
      </item2>
      <item3>
        <fundsSource>More than 60 days prior to the date of this Schedule 13D, T. Damadian acquired, personally, an aggregate of 42,700 shares of Common Stock, utilizing his own personal funds. In 2022, a trust for the benefit of T. Damadian acquired 127,482 shares of Class C common stock (convertible into 42,494 shares of Common Stock) as an inheritance in connection with the death of such Reporting Person's father, Raymond V. Damadian, the founder, former Chairman of the Board of Directors, principal Executive officer, and principal financial officer of the Company. Also in 2022, a second trust for the benefit of T. Damadian acquired 36,359 shares of Common Stock also as an inheritance in connection with the death of Raymond V. Damadian. T. Damadian has sole dispositive and voting power of the shares in both of such trusts.

More than 60 days prior to the date of this Schedule 13D, Bonanni acquired, personally, an aggregate of 7,027 shares of Common Stock utilizing his own personal funds. Bonanni was granted a total of 47,226 shares of Common Stock under the Issuer's 2010 Stock Bonus Plan in his capacity as an employee of the Issuer.

Lehman was granted by the Issuer 4,330 shares of Common Stock more than 60 days prior to the date of this Schedule 13D as part of his compensation package for being a member of the Bord of Directors of Issuer. No consideration was paid.

Rodrigo acquired the shares of Common Stock covered by this Schedule 13D from the Issuer more than 60 days prior to the date of this Schedule 13D pursuant to a bonus share grant made under the Issuer's 2010 Stock Bonus Plan and related to his employment with the Issuer's subsidiary HMCA. No consideration was paid.

In 2022, a trust for the benefit of J. Damadian acquired 127,482 shares of Class C common stock (convertible into 42,494 shares of Common Stock) as an inheritance in connection with the death of such Reporting Person's father, Raymond V. Damadian, the founder, former Chairman of the Board of Directors, principal Executive officer, and principal financial officer of the Company. Also in 2022, a second trust for the benefit of J. Damadian acquired 36,359 shares of Common Stock also as an inheritance in connection with the death of Raymond V. Damadian. J. Damadian has sole dispositive and voting power of the shares in both of such trusts.

Flanagan purchased 2,000 shares of Common Stock using personal funds for an aggregate purchase price of approximately $30,000 more than 60 days prior to the date of this Schedule 13D and was issued by the Issuer 6,851 shares of Common Stock more than 60 days prior to the date of this Schedule 13D pursuant to a bonus share grant made under the Issuer's 2010 Stock Bonus Plan and related to his employment with the Issuer's subsidiary HMCA.      Kurt William Reimann purchased 2,000 shares of Common Stock more than 60 days prior to the date of this Schedule 13D using personal funds in the amount of $27,621.05.

Veroline acquired the shares of Common Stock covered by this Schedule 13D from the Issuer more than 60 days prior to the date of this Schedule 13D pursuant to a bonus share grant made under the Issuer's 2010 Stock Bonus Plan and related to her employment with the Issuer's subsidiary HMCA. No consideration was paid.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>The Reporting Persons are filing this Schedule 13D to report a change in their intentions with respect to the ownership of the securities covered by this Schedule 13D. On July 7, 2025, the Reporting Persons formed a group intention to request that the Board of Directors of the Issuer enter into discussions with the Reporting Persons to negotiate the terms of a "going private transaction" whereby the Reporting Persons would acquire, through a newly formed entity, the securities of the Issuer not currently owned by them. The Reporting Persons delivered a letter to the Issuer's Board of Directors on July 7, 2025 (the "Letter") setting forth the terms of their non-binding proposal. A copy of the Letter is attached hereto as Exhibit 2 to this Schedule 13D and is incorporated herein by reference thereto. The Reporting Persons have engaged, and intend to continue to engage, in communications with one or more officers, directors, and/or representatives or agents of the Issuer and/or other persons, and may, in the future, also engage in communications with one or more shareholders of the Issuer and other relevant parties, regarding the Issuer and the going private transaction.

The Reporting Persons intend to review their investment in the Issuer on a continuing basis and may, at any time, change or reconsider their position and/or their purpose with regard to any or all of the foregoing. Depending on various factors including, without limitation, the Issuer's financial position and strategic direction, the outcome of the discussions and actions referenced above, actions which may be  taken by the Board of Directors of the Issuer, price levels of the Issuer's Common Stock, conditions in the securities market, and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, purchasing additional shares of Common Stock or selling some or all of their shares of Common Stock, engaging in short selling of, or any hedging or similar transactions with respect to, the shares of Common Stock and/or otherwise changing their intention with respect to any and all matters referred to in this Item 4.

There can be no assurance that the Reporting Persons will pursue any going private transaction or other transaction as described above and whether any such transaction will be consummated at all. Moreover, there can be no assurance that the Reporting Persons will or will not develop any alternative plans or proposals with respect to any of the foregoing matters or take any particular action or actions with respect to some or all of their holdings in the Issuer, or as to the timing of any such matters should they be so pursued by the Reporting Persons. The Reporting Persons reserve the right, at any time and in each  Reporting Person's sole discretion, to take or refrain from taking any of the actions set forth above.

Except as described in this Item 4 or would occur upon completion of any of the transactions discussed herein, as of the date of this statement the Reporting Persons have no present plan or proposal that relates to or would result in any of the matters set forth in subsections (a) through (j) of Item 4 of Schedule 13D.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>See items 11 and 13 of the cover pages to this Schedule 13D for the aggregate number of shares and percentage of Common Stock beneficially owned by each of the Reporting Persons, which such cover pages are incorporated herein by reference.
As of May 2, 2025, there were 6,203,465 shares of Common Stock issued and outstanding  according to the Issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed with the Securities and Exchange Commission on May 15, 2025. T. Damadian and Bonanni, as executive officers of the Issuer, do not believe there have been any change in such number of issued and outstanding shares of Common Stock.
As of the filing date of this Schedule 13D, T. Damadian is deemed to beneficially own 121,553 shares of Common Stock, including 42,494 shares of Common Stock into which 127,482 shares of Class C common stock held by T. Damadian or trusts in which he is trustee with dispositive and voting power over assets in such trusts are currently convertible. Accordingly, T. Damadian's the beneficial owner of approximately 1.9% of the shares of Common Stock currently issued and outstanding.
As of the filing date of this Schedule 13D, J. Damadian is deemed to beneficially own 78,853 shares of Common Stock, including 42,494 shares of Common Stock into which 127,482 shares of Class C common stock held by J. Damadian or trusts in which he is trustee with dispositive and voting power over assets in such trusts are currently convertible. Accordingly, J. Damadian's the beneficial owner of approximately 1.3% of the shares of Common Stock currently issued and outstanding.
The securities of Issuer deemed to be beneficially owned by T. Damadian and J. Damadian include shares of Common Stock which may be obtained upon conversion at any time of Series C Preferred Shares which are convertible into shares of Common Stock at the conversion rate of one share of Common Stock for each three shares of Series C Preferred Stock.
The shares of Series C Preferred Stock are entitled to 25 votes per share voting together with the Common Stock as a single class.</percentageOfClassSecurities>
        <numberOfShares>See items 7 through 10 of the cover pages to this Schedule 13D for the number of shares of Common Stock beneficially owned by each of the Reporting Persons as to which there is sole power to vote or to direct the vote, shared power to vote or to direct the vote and sole or shared power to dispose or to direct the disposition, which such cover pages are incorporated herein by reference.</numberOfShares>
        <transactionDesc>None of the Reporting Persons have effected any transactions in Common Stock during the past 60 days prior to the date of this Schedule 13D.</transactionDesc>
        <listOfShareholders>To the knowledge of the Reporting Persons, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, securities covered by this Schedule 13D.</listOfShareholders>
        <date5PercentOwnership>Not applicable.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>Except for the Joint Filing Agreement, dated as of July 11, 2025, attached as Exhibit 1 to this Schedule 13D, to the best knowledge of the Reporting Persons, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2 and between such persons and any persons with respect to any securities of the Issuer, including, but not limited to, transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Exhibit 1 - Joint Filing Agreement, dated as of July 11, 2025.
Exhibit 2 - Proposal Letter to the Board of Directors of Issuer dated July 7, 2025.</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Timothy Raymond Damadian</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Timothy Raymond Damadian</signature>
          <title>Timothy Raymond Damadian</title>
          <date>07/11/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Luciano Benedetto Bonanni</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Luciano Benedetto Bonanni</signature>
          <title>Luciano Benedetto Bonanni</title>
          <date>07/11/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Ronald George Lehman II</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Ronald George Lehman II</signature>
          <title>Ronald George Lehman II</title>
          <date>07/11/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Richard Alan Feigenbaum</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Richard Alan Feigenbaum</signature>
          <title>Richard Alan Feigenbaum</title>
          <date>07/11/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Xavier Patrick Rodrigo</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Xavier Patrick Rodrigo</signature>
          <title>Xavier Patrick Rodrigo</title>
          <date>07/11/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Jevan Damadian</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jevan Damadian</signature>
          <title>Jevan Damadian</title>
          <date>07/11/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>James Joseph Flanagan</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ James Joseph Flanagan</signature>
          <title>James Joseph Flanagan</title>
          <date>07/11/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Kurt William Reimann</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Kurt William Reimann</signature>
          <title>Kurt William Reimann</title>
          <date>07/11/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Janice Veroline</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Janice Veroline</signature>
          <title>Janice Veroline</title>
          <date>07/11/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>James Persoons</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ James Persoons</signature>
          <title>James Persoons</title>
          <date>07/11/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>2
<FILENAME>e6698_ex1.htm
<DESCRIPTION>EXHIBIT 1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 10pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>JOINT FILING AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">Pursuant to Rule 13d-1(k)(1) promulgated
under the Securities Exchange Act of 1934, as amended, each of the undersigned acknowledges and agrees that the foregoing statement on
Schedule 13D is filed on behalf of the undersigned with respect to their shares of common stock, par value $0.0001 per share, of FONAR
Corporation, a Delaware corporation, and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of
the undersigned without the necessity of filing additional joint acquisition statements. Each of the undersigned acknowledges that each
party hereto shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning
such party contained therein, but shall not be responsible for the completeness and accuracy of the information concerning any other party,
except to the extent that such party knows or has reason to believe that such information is inaccurate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dated: July 11, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid; width: 49%"><I>/s/ Timothy Damadian</I></TD>
  <TD STYLE="width: 2%"><I>&nbsp;</I></TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 49%"><I>&#9;/s/ Luciano Bonanni</I></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Timothy Raymond Damadian</TD>
  <TD>&nbsp;</TD>
  <TD>Timothy Raymond Damadian</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid"><I>/s/ Ronald Lehman</I></TD>
  <TD><I>&nbsp;</I></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><I>&#9;/s/ Richard Feigenbaum</I></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Ronald George Lehman II</TD>
  <TD>&nbsp;</TD>
  <TD>&#9;Richard Alan Feigenbaum</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid"><I>/s/ Xavier Rodrigo</I></TD>
  <TD><I>&nbsp;</I></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><I>&#9;/s/ Jevan Damadian</I></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Xavier Patrick Rodrigo</TD>
  <TD>&nbsp;</TD>
  <TD>&#9;Jevan Damadian</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid"><I>/s/ James Joseph Flanagan</I></TD>
  <TD><I>&nbsp;</I></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><I>&#9;/s/ Kurt Reimann</I></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>James Joseph Flanagan</TD>
  <TD>&nbsp;</TD>
  <TD>&#9;Kurt William Reimann</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid"><I>/s/ Janice Veroline</I></TD>
  <TD><I>&nbsp;</I></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><I>&#9;/s/ James Persoons</I></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>Janice Veroline</TD>
  <TD>&nbsp;</TD>
  <TD>&#9;James Persoons</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2
<SEQUENCE>3
<FILENAME>e6698_ex2.htm
<DESCRIPTION>EXHIBIT 2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 10pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: right"><B>EXHIBIT 2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>TIM DAMADIAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>110 Marcus Drive</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Melville, New York 11747-4292</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">July
7, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 4in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>VIA EMAIL AND FIRST CLASS MAIL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">FONAR Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">110 Marcus Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Melville, New York 11747-4292</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Ronald.Lehman@gmail.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Ricky.Turk@gmail.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Jessicajmaher4@gmail.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">RCarrino254@gmail.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dear Sirs and Madams:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">I wish to inform you that I, along with certain other members of the management
team and Board of Directors of FONAR Corporation (&ldquo;<B>FONAR</B>&rdquo;) and third parties (collectively, the &ldquo;<B>Proposed
Acquisition Group</B>&rdquo;), are contemplating the pursuit of a plan to acquire all of the outstanding shares of capital stock of FONAR
not owned by members of the Proposed Acquisition Group in a &ldquo;going private&rdquo; transaction (&ldquo;<B>Acquisition Transaction</B>&rdquo;).
The Proposed Acquisition Group is submitting to the Board of Directors of FONAR this preliminary, non-binding proposal to acquire all
of the outstanding capital stock of FONAR (the &ldquo;<B>FONAR Stock</B>&rdquo;) not currently owned by the Proposed Acquisition Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">The Proposed Acquisition Group currently beneficially owns approximately
5.01% of the outstanding FONAR Stock.<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>[1]</SUP></FONT> The current members
of the Proposed Acquisition Group currently include myself, Luciano B. Bonanni, Ronald G. Lehman, Richard Feigenbaum, Xavier Rodrigo,
Jevan Damadian, Jim Flanagan, Kurt Reimann, Janice Veroline, and James Persoons. We expect that the members of the Proposed Acquisition
Group will be expanded as we solidify our offer and our financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">The Acquisition Group believes that an Acquisition Transaction, at a price
per share to be negotiated, will provide a very attractive opportunity to FONAR&rsquo;s public shareholders to cash out of their investment
in FONAR Stock. We anticipate that the per share price for the FONAR Stock held by the public stockholders would be at a premium of no
less than 10% to the average closing market price of FONAR&rsquo;s common stock for the 90 trading days immediately preceding July 1,
2025, such immediately preceding day being the last day of FONAR&rsquo;s 2024-2025 fiscal year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>[1]</SUP></FONT></TD><TD STYLE="text-align: justify">For purposes of this proposal letter, references to the Proposed Group&rsquo;s ownership of FONAR Stock include the currently issued
and outstanding shares of FONAR&rsquo;s common stock, and FONAR&rsquo;s Class A non-voting preferred stock, Class B convertible common
stock, and Class C common stock on an as-converted basis.</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TIMOTHY R. DAMADIAN</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board of Directors</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FONAR Corporation</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 7, 2025</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page - 2 -</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">Certain of the terms and conditions upon which the Proposed Acquisition
Group is prepared to pursue the Acquisition Transaction are set forth below. The Acquisition Group is confident in its ability to consummate
the Acquisition Transaction as outlined in this letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Acquiror</U>. It is anticipated
that the Proposed Acquisition Group will use a special purpose vehicle, likely, a Delaware limited liability company (the &ldquo;<B>Acquisition
Vehicle</B>&rdquo;), for the purpose of pursuing the Acquisition Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Structure of the Acquisition
Transaction; Merger Consideration</U>. The structure of the Acquisition Transaction is expected to be a merger (the &ldquo;<B>Merger</B>&rdquo;)
of a wholly owned subsidiary of Acquisition Vehicle, currently contemplated to be a Delaware corporation (&ldquo;<B>Merger Sub</B>&rdquo;),
with and into FONAR, with FONAR surviving the merger. In this letter we refer to Acquisition Vehicle, Merger Sub and FONAR, collectively,
as the <B>&ldquo;Transaction Parties</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">As contemplated, preceding the Merger, the members of the Proposed Acquisition
Group will contribute all of their respective holdings of FONAR Stock (&ldquo;<B>Proposed Acquisition Group&rsquo;s FONAR Stock</B>&rdquo;)
to Acquisition Vehicle. As further contemplated, upon consummation of the Merger, all of the Proposed Acquisition Group&rsquo;s FONAR
Stock will be cancelled and all other shares of FONAR Stock then issued and outstanding and held by persons and entities other than the
those held directly or indirectly by the Proposed Acquisition Group (the &ldquo;<B>Public Shares</B>&rdquo;) will be converted into a
right to receive the per share merger consideration as determined in our negotiations, payable in cash upon consummation of the Merger.
Acquisition Vehicle&rsquo;s 100% ownership of Merger Sub immediately prior to the effectiveness of the Merger will, as a result of the
Merger, automatically convert into a 100% equity ownership by Acquisition Vehicle of the post-Merger FONAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">While it is anticipated that the FONAR Stock held by the members of the
Proposed Acquisition Group (or Acquisition Vehicle) will be voted in favor of the approval of the merger agreement for the Acquisition
Transaction, it is contemplated that the merger agreement will require for its approval that a majority of the FONAR Stock held by all
FONAR stockholders other than the Proposed Acquisition Group (and Acquisition Vehicle, if any) be voted for approval of the merger agreement,
commonly referred to as a &ldquo;majority of the minority&rdquo; vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Financing</U>. The Proposed
Acquisition Group intends to finance the Acquisition with a combination of equity investments and debt financing, as well as FONAR&rsquo;s
available cash. The Proposed Acquisition Group is confident that it can timely secure adequate debt financing and additional equity capital
to consummate the Acquisition Transaction, and we expect the Acquisition Transaction would not be subject to any financing condition at
the time the merger agreement is executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TIMOTHY R. DAMADIAN</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board of Directors</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FONAR Corporation</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 7, 2025</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page -3  -</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Due Diligence</U>. While
certain members of the Proposed Acquisition Group are executive officers and/or directors of FONAR and, accordingly, are familiar with
FONAR and have access to FONAR&rsquo;s books and records, other members of the Proposed Acquisition Group, including third parties who
may, in the future, become members of the Proposed Acquisition Group, as well as our financing partners, will need to conduct their own
due diligence, which would require reviewing the books and records of FONAR and have access to FONAR&rsquo;s management to make appropriate
due diligence inquiries. Accordingly, the members and potential members of the Proposed Acquisition Group will require access to FONAR&rsquo;s
books, records, and management personnel, subject their individual execution of an appropriate confidentiality, non-disclosure, and non-use
agreement with FONAR. The members of the Acquisition Group with current access to FONAR&rsquo;s books and records, including myself, and
the other senior management and directors of FONAR, are cognizant of their fiduciary duties and statutory obligations regarding disclosure
of non-public information concerning FONAR and will abide by their respective duties and obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitive Agreements</U>.
The Proposed Acquisition Group is prepared to negotiate and finalize a definitive merger agreement and related agreements typical for
transactions similar in nature to the Acquisition Transaction (collectively, the &ldquo;<B>Definitive Agreements</B>&rdquo;) concurrently
with the aforementioned due diligence reviews. The proposed Acquisition Transaction is subject to execution of the applicable Definitive
Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Confidentiality</U>. The
Proposed Acquisition Group will, as required by applicable law and SEC regulations, promptly file a Schedule 13D to disclose their current
intention to investigate proceeding with the proposed Acquisition Transaction, and material actions taken in furtherance thereof. The
Proposed Acquisition Group is sure you will agree with them that it is in all of the Parties&rsquo; interests to ensure that negotiations
between the Transaction Parties proceed in a confidential manner, unless otherwise required by law, until the Parties have agreed upon
a definitive plan for the Merger and related matters and executed the Definitive Agreements, or terminated our discussions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Process</U>. The Proposed
Acquisition Group believes that the Acquisition Transaction will provide superior value to FONAR&rsquo;s shareholders. The Proposed Acquisition
Group recognizes, of course, that you, the FONAR Board of Directors (the &ldquo;<B>Board</B>&rdquo;) will evaluate the proposed Acquisition
Transaction independently before the Board and any special committee of uninterested directors can make their determinations whether or
not to proceed with the proposed Acquisition Transaction. I, along with the other directors who are members of the Proposed Acquisition
Group, will recuse ourselves from any Board discussion or evaluation relating to the Acquisition Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Counsel</U>. We have retained
Moritt Hock &amp; Hamroff LLP as our legal counsel in connection with this proposal and the Acquisition Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TIMOTHY R. DAMADIAN</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board of Directors</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FONAR Corporation</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 7, 2025</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page -4  -</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Binding Commitment</U>.
This letter constitutes only a preliminary indication of our interest, and does not constitute any binding commitment with respect to
an Acquisition. Such a commitment will result only from the execution of the Definitive Agreements, and then will be on the terms provided
in such documentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Other Matters</U>. Although
the Board may choose to seek other competing offers to acquire FONAR, please note that I, personally, as a holder of FONAR Stock, will
not support or vote in favor of any alternative transaction submitted or proposed by any third party or parties. Other members of the
Proposed Acquisition Group may feel similarly. Notwithstanding such lack of support for an alternative transaction, kindly note that those
members of the Proposed Acquisition Group who are part of the management team or directors of FONAR, including myself, will continue to
abide by our respective fiduciary duties to FONAR and all of FONAR&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">In closing, the Proposed Acquisition Group would like to express its commitment
to working together with the Board to bring the Acquisition Transaction to a successful and timely conclusion. Should you have any questions
regarding this proposal, please do not hesitate to contact me. I look forward to speaking with you regarding this letter, the Proposed
Acquisition Group, the Acquisition Transaction and all matters relating thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Timothy R. Damadian</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Timothy R. Damadian,</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On behalf of the</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposed Acquisition Group, and, where noted, personally</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
